IMAGe (@indmyacgp) 's Twitter Profile
IMAGe

@indmyacgp

Society

ID: 1518222836766490624

calendar_today24-04-2022 13:39:05

390 Tweet

323 Followers

314 Following

Uday Yanamandra (@udayyanamandra) 's Twitter Profile Photo

Does the dose of Dexamethasone matter in the management of MM? Tune into the IMAGe Journal club on 22 May at 1730h IST for a better understanding of the long-considered backbone of MM therapy. Also, hear about the MM care in Sri Lanka. Rahul Banerjee, MD, FACP Buddhika Somawardana

Does the dose of Dexamethasone matter in the management of MM? Tune into the <a href="/IndMyAcGp/">IMAGe</a> Journal club on 22 May at 1730h IST for a better understanding of the long-considered backbone of MM therapy. Also, hear about the MM care in Sri Lanka. <a href="/RahulBanerjeeMD/">Rahul Banerjee, MD, FACP</a> <a href="/buddhikaprabat3/">Buddhika Somawardana</a>
Goutham Sunny (@medoncodoc) 's Twitter Profile Photo

📊 Systematic Review of Amyloidosis in India sheds light on important differences vs Western data—highlighting distinct patterns in demographics, disease subtypes, and clinical presentation. 🇮🇳🧬 🧓 Median age of Indian AL amyloidosis patients is ~50 yrs (a decade younger than

Uday Yanamandra (@udayyanamandra) 's Twitter Profile Photo

Welcome you all to this month's IMAGe Journal Club discussing the role of Dara with Len as post ASCT maintenance and the role of Zoledronic acid in preventing bone disease in MM. Presented & moderated by #CMCLudhiana

Welcome you all to this month's <a href="/IndMyAcGp/">IMAGe</a> Journal Club discussing the role of Dara with Len as post ASCT maintenance and the role of Zoledronic acid in preventing bone disease in MM. Presented &amp; moderated by #CMCLudhiana
Nitin Jain (@nitinjainmd) 's Twitter Profile Photo

👉Had a great time interacting with Hematology team at PGI Chandigarh We had a marathon session of 6 hours! discussing CLL and ALL therapies, including patient case discussions Many Thanks Pankaj Malhotra DrArihant@jain Charanpreet Singh and many others for active participation and

👉Had a great time interacting with Hematology team at PGI Chandigarh
We had a marathon session of 6 hours! discussing CLL and ALL therapies, including patient case discussions 
Many Thanks <a href="/DrPMPGI/">Pankaj Malhotra</a> <a href="/ArihantDr/">DrArihant@jain</a> <a href="/Charanpreet_14/">Charanpreet Singh</a> and many others for active participation and
Pankaj Malhotra (@drpmpgi) 's Twitter Profile Photo

Thank you for the enriching session and insightful discussions! Truly appreciated your time, energy, and expertise. The PGI Hematology team thoroughly enjoyed the interaction and looks forward to more such academic engagements in the future.

Dr.Nitin Yashas (@drnitinyashas) 's Twitter Profile Photo

Excited to be attending this academic feast on #myeloma at the IMF Asian myeloma network masterclass in Singapore Gratitude to Uday Yanamandra and IMAGe for this wonderful opportunity

Excited to be attending this academic feast on #myeloma at the IMF Asian myeloma network masterclass in Singapore 
Gratitude to <a href="/UdayYanamandra/">Uday Yanamandra</a> and <a href="/IndMyAcGp/">IMAGe</a> for this wonderful opportunity
Dr Rudra Narayan swain M.D (@rudra09s025) 's Twitter Profile Photo

bct.apbmt.org/articles/bct-2… 🧵5 Key Takeaways from Our Study on Composite MRD in Myeloma ASCT👇 📍Published in Blood Cell Therapy (APBMT) 1.🔍 Pre-ASCT cMRD negativity = better outcomes → 3-yr TTNT: 91% vs. 67% (p=0.027) 2.📊 Pre-ASCT MRD more predictive than post-ASCT → Post-ASCT

bct.apbmt.org/articles/bct-2…

🧵5 Key Takeaways from Our Study on Composite MRD in Myeloma ASCT👇
📍Published in Blood Cell Therapy (APBMT)
1.🔍 Pre-ASCT cMRD negativity = better outcomes
→ 3-yr TTNT: 91% vs. 67% (p=0.027)
2.📊 Pre-ASCT MRD more predictive than post-ASCT
→ Post-ASCT
Uday Yanamandra (@udayyanamandra) 's Twitter Profile Photo

Dive into the latest breakthroughs in myeloma research and translational insights by joining us for the next edition of the IMAGe Journal Club on 28 Aug. Theme: Best of ASCO & EHA 2025 presented by Aditya Jandial, MD, DM & Nikhil Kumar, moderated by Pankaj Malhotra & Dr Chandramouli.

Dive into the latest breakthroughs in myeloma research and translational insights by joining us for the next edition of the <a href="/IndMyAcGp/">IMAGe</a> Journal Club on 28 Aug. Theme: Best of ASCO &amp; EHA 2025 presented by <a href="/Aditya_PGI/">Aditya Jandial, MD, DM</a> &amp; <a href="/nikhil91sjmc/">Nikhil Kumar</a>, moderated by <a href="/DrPMPGI/">Pankaj Malhotra</a>  &amp; Dr Chandramouli.
Rahul Banerjee, MD, FACP (@rahulbanerjeemd) 's Twitter Profile Photo

Excellently written #CLML article about myeloma treatment in South Asia. 70% of #MMsm expenditures in 🇮🇳 🇵🇰 🇱🇰 🇧🇩 et al paid out of pocket by pts. Over half of public institutions don't have access to FLC testing, let alone SPEP... We have work to do! sciencedirect.com/science/articl…

Excellently written #CLML article about myeloma treatment in South Asia.

70% of #MMsm expenditures in 🇮🇳 🇵🇰 🇱🇰 🇧🇩 et al paid out of pocket by pts.

Over half of public institutions don't have access to FLC testing, let alone SPEP... We have work to do!

sciencedirect.com/science/articl…
Pankaj Malhotra (@drpmpgi) 's Twitter Profile Photo

Grateful to Shaji Kumar & Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 for their mentorship on this study. Hoping collaborations across these nations will strengthen myeloma care in the region #Myeloam #MedTwitter

Pankaj Malhotra (@drpmpgi) 's Twitter Profile Photo

Congratulations Team IMS for hosting a crucial breakfast session on improving drug availability & accessibility in LMICs—home to 70% of myeloma patients. Congrats Uday Yanamandra representing IMAGe. A big step toward better health for all myeloma patients. #IMS

Congratulations Team IMS for hosting a crucial breakfast session on improving drug availability &amp; accessibility in LMICs—home to 70% of myeloma patients. Congrats <a href="/UdayYanamandra/">Uday Yanamandra</a> representing <a href="/IndMyAcGp/">IMAGe</a>. A big step toward better health for all myeloma patients. #IMS
Nikhil Kumar (@nikhil91sjmc) 's Twitter Profile Photo

RahulDoc Vincent Rajkumar Rahul Banerjee, MD, FACP Shrinidhi Nathany Pankaj Malhotra This slide from an incredible talk by Vincent Rajkumar couple of years back at IMAGe meeting at Pune . With recent data showing excellent responses with upfront bispecific combinations , I am inclined to choose the last 2 options !!

<a href="/RahulDoc2/">RahulDoc</a> <a href="/VincentRK/">Vincent Rajkumar</a> <a href="/RahulBanerjeeMD/">Rahul Banerjee, MD, FACP</a> <a href="/drshrinidhi2020/">Shrinidhi Nathany</a> <a href="/DrPMPGI/">Pankaj Malhotra</a> This slide from an incredible talk by <a href="/VincentRK/">Vincent Rajkumar</a> couple of years back at <a href="/IndMyAcGp/">IMAGe</a> meeting at Pune . With recent data showing excellent responses with upfront bispecific combinations , I am inclined to choose the last 2 options !!
Prantar Chakrabarti 3.0 (@prantar) 's Twitter Profile Photo

Clear, precise communication with embedded action points. A masterclass on how to write a review article. Must read for all physicians. Thanks Vincent Rajkumar Shaji Kumar #monoclonalgammopathy #MGUS #MGRS #MGCS IMAGe Pankaj Malhotra Uday Yanamandra Nikita Mehra